Douglas A Treco's Net Worth
$11.6 Million
Who is Douglas A Treco?
Douglas A Treco has an estimated net worth of $11.6 Million. This is based on reported shares across multiple companies, which include CRISPR Therapeutics AG, Inozyme Pharma, Inc., and Ra Pharmaceuticals, Inc..
SEC CIK
Douglas A Treco's CIK is 0001688192
Past Insider Trading and Trends
2023 was Douglas A Treco's most active year for acquiring shares with 3 total transactions. Douglas A Treco's most active month to acquire stocks was the month of May. 2020 was Douglas A Treco's most active year for disposing of shares, totalling 8 transactions. Douglas A Treco's most active month to dispose stocks was the month of March. 2023 saw Douglas A Treco paying a total of $0.00 for 913,000 shares, this is the most they've acquired in one year. In 2020 Douglas A Treco cashed out on 1,461,656 shares for a total of $11,265,936.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +548.21% | 17.48K |
$6.94 | -$52,209.62 | 20.66K |
Apr 1 - Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ra Pharmaceuticals, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -234.71K |
$48.00 | -$11,265,936.00 |
0
|
Apr 2
| |||
Form 4
| +7.10% | 14.51K |
$21.00 | -$132,867.00 | 218.8K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||